Delivery Order SPE2DB22D3016-SPE2DB24FALG2
Award Date
2/2/24
Potential Completion Date
2/5/24
Potential Value
$3.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,148.63 firm fixed-price delivery order is for the supply of OSELTAMIVIR 6 MG/ML SUSPENSION 60ML, a pharmaceutical product. The contract has a completion date of December 18, 2023 and was awarded on December 15, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 60 ml bottles of the pharmaceutical product oseltamivir 6 mg/ml suspension. The $2,980.40 contract has a completion date of February 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 4,563,850,464 units of Oseltamivir Phosphate 75 mg capsules. The contract has a potential value of $1,025.95 and a completion date of March 5, 2024. This delivery order is part of Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025,...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical valued at $1,512.96 to provide Oseltamivir Phosphate 75 mg capsules. This delivery order is part of an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,742.98 firm fixed-price delivery order is for the supply of 4,566,975,174 units of OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S, with a completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,394,389 units of Oseltamivir Phosphate 75 mg capsules. The contract has an ultimate completion date of January 23, 2024 and a ceiling value of $3,630.81. The award is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $4,087.36, is for the procurement of 4,567,218,221 units of Oseltamivir Phosphate 75 mg Capsules. The contract has a period of performance through February 11, 2025 and was awarded on February 10, 2025. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of oseltamivir phosphate 75 mg capsules. The award has a potential value of $1,123.43 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not part of a set-aside contract. This award is issued under a larger indefinite delivery contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OSELTAMIVIR PHOS 75 MG CAPSULE UD 10S medical supplies. The contract, valued at $1,884.96, is a delivery order with a firm fixed price and an ultimate completion date of January 18, 2024. AmerisourceBergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999,...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,262.36, is a delivery order for 4,567,154,351 units of the antiviral medication Oseltamivir Phosphate 75 mg capsules. The contract has a completion date of February 5, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...